Tucatinib is a treatment for people with HER2-positive breast cancer that’s moved to the brain. It falls into the category of drugs known as HER2 inhibitors.
Tucatinib stops the HER2 receptor from working. This receptor is big in how cancer cells grow and reproduce.Dosage Details:You can get it in two strengths: 50 mg and 150 mg tablets with a coating.The doc usually says to take 300 mg twice daily on an empty stomach.Each pack has a bottle with 60 tablets in it.It can be given through a vein or taken by mouth, depending on what the patient needs.Clinical trials have shown that it can help with brain tumors in HER2-positive breast cancer by going straight after the HER2 pathway.
